Literature DB >> 23757222

The adolescent and young adult with cancer: state of the art-- acute leukemias.

M Monica Gramatges1, Karen R Rabin.   

Abstract

Despite survival gains over the past several decades, adolescent and young adult (AYA) patients with both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) demonstrate a consistent survival disadvantage. The AYA population exhibits unique disease and host characteristics, and further study is needed to improve their outcomes. This review will highlight distinctive aspects of disease biology in this population, as well as salient treatment-related toxicities including osteonecrosis, pancreatitis, thromboembolism, hyperglycemia, and infections. The impact of obesity and differences in drug metabolism and chemotherapy resistance will also be discussed, as well as optimal treatment considerations for the AYA population.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23757222      PMCID： PMC3758222          DOI： 10.1007/s11912-013-0325-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  68 in total

1.  Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.

Authors:  P Zuccaro; S Guandalini; R Pacifici; S Pichini; L Di Martino; M Guiducci; M Giuliano; M T Di Tullio; M Pettoello Mantovani
Journal:  Ther Drug Monit       Date:  1991-01       Impact factor: 3.681

2.  Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jonathan Bond; Stuart Adams; Susan Richards; Ajay Vora; Christopher Mitchell; Nicholas Goulden
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

Review 3.  Clinical pharmacology in the adolescent oncology patient.

Authors:  Gareth J Veal; Christine M Hartford; Clinton F Stewart
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

4.  Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.

Authors:  C D Mitchell; S M Richards; S E Kinsey; J Lilleyman; A Vora; T O B Eden
Journal:  Br J Haematol       Date:  2005-06       Impact factor: 6.998

5.  Improved prognosis for older adolescents with acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Deqing Pei; Dario Campana; W Paul Bowman; John T Sandlund; Sue C Kaste; Raul C Ribeiro; Jeffrey E Rubnitz; Elaine Coustan-Smith; Sima Jeha; Cheng Cheng; Monika L Metzger; Deepa Bhojwani; Hiroto Inaba; Susana C Raimondi; Mihaela Onciu; Scott C Howard; Wing Leung; James R Downing; William E Evans; Mary V Relling
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

6.  Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

Authors:  Stephen P Hunger; Xiaomin Lu; Meenakshi Devidas; Bruce M Camitta; Paul S Gaynon; Naomi J Winick; Gregory H Reaman; William L Carroll
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

Review 7.  Childhood and adolescent lymphoid and myeloid leukemia.

Authors:  Ching-Hon Pui; Martin Schrappe; Raul C Ribeiro; Charlotte M Niemeyer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

8.  Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.

Authors:  Elly Barry; Daniel J DeAngelo; Donna Neuberg; Kristen Stevenson; Mignon L Loh; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; Harvey J Cohen; Stephen E Sallan; Lewis B Silverman
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

Review 9.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

10.  Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

Authors:  Josep-María Ribera; Albert Oriol; Miguel-Angel Sanz; Mar Tormo; Pascual Fernández-Abellán; Eloy del Potro; Eugenia Abella; Javier Bueno; Ricardo Parody; Pilar Bastida; Carlos Grande; Inmaculada Heras; Concepción Bethencourt; Evarist Feliu; Juan-José Ortega
Journal:  J Clin Oncol       Date:  2008-04-10       Impact factor: 44.544
View more
  14 in total

1.  Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

Authors:  Catherine J Lee; Soyoung Kim; Heather R Tecca; Stephanie Bo-Subait; Rachel Phelan; Ruta Brazauskas; David Buchbinder; Betty K Hamilton; Minoo Battiwalla; Navneet S Majhail; Hillard M Lazarus; Peter J Shaw; David I Marks; Mark R Litzow; Saurabh Chhabra; Yoshihiro Inamoto; Zachariah DeFilipp; Gerhard C Hildebrandt; Richard F Olsson; Kimberly A Kasow; Jane L Liesveld; Seth J Rotz; Sherif M Badawy; Neel S Bhatt; Jean A Yared; Kristin M Page; Martha L Arellano; Michael Kent; Nosha Farhadfar; Sachiko Seo; Peiman Hematti; César O Freytes; Alicia Rovó; Siddhartha Ganguly; Sunita Nathan; Linda Burns; Bronwen E Shaw; Lori S Muffly
Journal:  Blood Adv       Date:  2020-03-24

2.  Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.

Authors:  Nishi Kothari; Jamie K Teer; Andrea M Abbott; Thejal Srikumar; Yonghong Zhang; Sean J Yoder; Andrew S Brohl; Richard D Kim; Damon R Reed; David Shibata
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

3.  Anxiety, depression, stress, and cortisol levels in mothers of children undergoing maintenance therapy for childhood acute lymphoblastic leukemia.

Authors:  Madalynn Neu; Ellyn Matthews; Nancy A King; Paul F Cook; Mark L Laudenslager
Journal:  J Pediatr Oncol Nurs       Date:  2014 Mar-Apr       Impact factor: 1.636

4.  Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patients.

Authors:  Riad El Fakih; Ahmed Kotb; Shahrukh Hashmi; Naeem Chaudhri; Fahad Alsharif; Marwan Shaheen; Ahmad Alshomar; Amr Hanbali; Feras Alfraih; Saud Alhayli; Hussein Albarqi; Budur Alnefaie; Tusneem Elhassan; Husam Alsadi; Riad Youniss; Ali Alahmari; Walid Rasheed; Hazzaa Alzahrani; Fahad Almohareb; Syed Ahmed; Mahmoud Aljurf
Journal:  Bone Marrow Transplant       Date:  2019-09-05       Impact factor: 5.483

5.  Psychosocial Experiences of Young Adults Diagnosed With Acute Leukemia During Hospitalization for Induction Chemotherapy Treatment.

Authors:  Tara A Albrecht; Jessica Keim-Malpass; Michael Boyiadzis; Margaret Rosenzweig
Journal:  J Hosp Palliat Nurs       Date:  2019-04       Impact factor: 1.918

6.  A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.

Authors:  Virginia Perez-Andreu; Kathryn G Roberts; Heng Xu; Colton Smith; Hui Zhang; Wenjian Yang; Richard C Harvey; Debbie Payne-Turner; Meenakshi Devidas; I-Ming Cheng; William L Carroll; Nyla A Heerema; Andrew J Carroll; Elizabeth A Raetz; Julie M Gastier-Foster; Guido Marcucci; Clara D Bloomfield; Krzysztof Mrózek; Jessica Kohlschmidt; Wendy Stock; Steven M Kornblau; Marina Konopleva; Elisabeth Paietta; Jacob M Rowe; Selina M Luger; Martin S Tallman; Michael Dean; Esteban G Burchard; Dara G Torgerson; Feng Yue; Yanli Wang; Ching-Hon Pui; Sima Jeha; Mary V Relling; William E Evans; Daniela S Gerhard; Mignon L Loh; Cheryl L Willman; Stephen P Hunger; Charles G Mullighan; Jun J Yang
Journal:  Blood       Date:  2014-12-02       Impact factor: 22.113

7.  Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data.

Authors:  Sherlly Xie; Md Jobayer Hossain
Journal:  Cancer Epidemiol       Date:  2018-03-16       Impact factor: 2.984

8.  Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.

Authors:  Md Jobayer Hossain; Li Xie
Journal:  Cancer Epidemiol       Date:  2015-11-09       Impact factor: 2.984

9.  Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).

Authors:  Naveen Pemmaraju; Hagop Kantarjian; Farhad Ravandi; Graciela M Nogueras-Gonzalez; Xuelin Huang; Susan O'Brien; William Wierda; Guillermo Garcia-Manero; Deborah Thomas; Sherry Pierce; Srdan Verstovsek; Gautam Borthakur; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-01-05

Review 10.  Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients.

Authors:  Guldane Cengiz Seval; Muhit Ozcan
Journal:  J Clin Med       Date:  2015-03-11       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.